Rani Therapeutics Holdings, Inc. (RANI)

RANI Revenue

In the year 2025, Rani Therapeutics Holdings had annual revenue of $1.63M with 58.85% growth. Rani Therapeutics Holdings had revenue of $1.46M in the quarter ending December 31, 2025, with 42.12% growth.

• Revenue (ttm): $1.63M
• Revenue Growth: +58.85%
• P/S Ratio: 54.03
• Revenue / Employee: $23,000
• Employees: 71
• Market Cap: 95.82M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.63M	605.00K	58.85%
Dec 31, 2024	1.03M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	2.72M	2.26M	488.10%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 2, 2026

Data Sources Report a data error